Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bausch Health Companies Inc
(TSX:
BHC
)
7.910
+0.080 (+1.02%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bausch Health Companies Inc
< Previous
1
2
3
Next >
Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis
December 21, 2023
Via
ACCESSWIRE
DUOBRII(TM) Lotion to Treat Moderate to Severe Plaque Psoriasis Now Available Through Quebec’s Public Drug Plan
December 18, 2023
Via
ACCESSWIRE
Salix in Collaboration with The U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders Establish the Inaugural Opioid-Induced Constipation (OIC) Awareness Day
December 05, 2023
Via
ACCESSWIRE
The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis
November 10, 2023
Via
ACCESSWIRE
CORRECTION BY SOURCE: The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis
November 10, 2023
Via
ACCESSWIRE
Bausch Health Unveils "Looking Forward" - A New DTC Television Campaign for Seasonal Affective Disorder (SAD)
October 26, 2023
Via
ACCESSWIRE
Salix Pharmaceuticals Partners with Bellamy Young
October 04, 2023
Via
ACCESSWIRE
League of United Latin American Citizens (LULAC) Joins OraPharma in the Fight Against Gum Disease
September 21, 2023
Via
ACCESSWIRE
As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD)
November 08, 2023
Via
ACCESSWIRE
Bausch Health Announces Third-Quarter 2023 Results
November 02, 2023
Via
ACCESSWIRE
U.S. District Court Dismisses Norwich's Lawsuit Against the FDA
November 01, 2023
Via
ACCESSWIRE
FDA Approves Cabtreo(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel for the Treatment of Acne Vulgaris in Patients Twelve Years of Age and Older
October 20, 2023
Via
ACCESSWIRE
New Analysis Indicates That a Majority of Overt Hepatic Encephalopathy (OHE) Patients May Face Delays in Treatment Initiation and Gaps During Treatment for Access to Treatment Indicated to Reduce Risk for OHE Recurrence
October 17, 2023
Via
ACCESSWIRE
Bausch Health to Announce Third-Quarter 2023 Results on Nov. 2
October 12, 2023
Via
ACCESSWIRE
Ortho Dermatologics Announces 2023 Aspire Higher Scholarship Recipients
July 27, 2023
Via
ACCESSWIRE
Salix Announces 2023 Gastrointestinal Health Scholars Program Winners
July 11, 2023
Via
ACCESSWIRE
Salix to Present Data from XIFAXAN(R) (Rifaximin) Clinical Research at EASL's International Liver Congress(TM) 2023
June 19, 2023
Via
ACCESSWIRE
Salix Pharmaceuticals Releases Liver Health Annual Trends Report Identifying Increase in Chronic Liver Disease and Cirrhosis-Related Deaths Marking These as Ninth Leading Cause of Death in U.S.
October 10, 2023
Via
ACCESSWIRE
Bausch Health's Bausch + Lomb Announces Completion of the Acquisition of XIIDRA(R)
September 29, 2023
Via
ACCESSWIRE
Bausch Health Announces CFO Transition Plan
September 18, 2023
Via
ACCESSWIRE
New Bausch Health Treatment PrUCERIS(R) (budesonide) Aerosol Foam Now Available Across Canada to Treat Mild to Moderate Distal Ulcerative Colitis in Adults
September 12, 2023
Via
ACCESSWIRE
Bausch Health's Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA(R)
September 11, 2023
Via
ACCESSWIRE
Bausch Health's Bausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA(R)
September 06, 2023
Via
ACCESSWIRE
Bausch Health Announces Second-Quarter 2023 Results, Other Key Updates From the Quarter, and Raises Full-Year 2023 Revenue Outlook
August 03, 2023
Via
ACCESSWIRE
Bausch Health to Announce Second-Quarter 2023 Results on Aug. 3
July 13, 2023
Via
ACCESSWIRE
OraPharma to Participate in the First-Ever Research and Technology Pavilion Sponsored by Pacific Dental Services(R) at the American Dental Hygienists' Association (ADHA(R)) Annual Conference
July 07, 2023
Via
ACCESSWIRE
Bausch Health Enters Into $600 Million Financing Facility With KKR
July 07, 2023
Via
ACCESSWIRE
Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)
June 30, 2023
Via
ACCESSWIRE
Bausch Health Responds to Norwich's ANDA Tentative Approval and Lawsuit Against United States Food and Drug Administration
June 06, 2023
Via
ACCESSWIRE
New Clinical Study Suggests the Use of OraPharma’s ARESTIN(R) (minocycline HCl) Microspheres, 1mg May Decrease Certain Pathogens in Adults with Periodontitis
May 18, 2023
Via
ACCESSWIRE
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.